Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.